Grab Stock And 2 Penny Stocks With Strong Balance Sheet Backing

Grab Holdings

Grab Holdings

GRAB

0.00

Penny stocks carry a reputation for excitement and risk, but the Financially Fit Penny Stocks screener narrows the field to companies trading below 5 that also show signs of solid financial health. With investors watching inflation, central bank signals and bond yields closely, many are looking for potential growth without taking on excessive balance sheet risk. This screener filters for that combination, aiming to highlight early stage stocks where financial strength is a key feature. In this article, you will see three of the strongest candidates from the screener that stand out for further research.

Grab Holdings (GRAB)

Overview: Grab Holdings runs a superapp across eight Southeast Asian countries that brings together ride hailing, food and package delivery, digital payments and banking style services in a single ecosystem for consumers, drivers and merchants. The company also offers advertising, mapping, insurance and vehicle rental services, aiming to be a daily utility for transport, commerce and finance in the region.

Operations: Grab generates most of its revenue from Deliveries at US$1.9b and Mobility at US$1.3b, with smaller contributions from Financial Services at US$379m and Others at US$4m.

Market Cap: US$16.1b

Grab Holdings stands out in this screener because it combines a superapp business model across mobility, deliveries and fintech with rising earnings and net profit margins that have improved sharply year over year. Analysts expect both revenue and earnings growth to run ahead of the broader US market. However, the stock trades well below one estimate of fair value based on future cash flows. This suggests investors are still cautious about its high P/E and heavy use of non cash earnings. The company’s expanding digital banking push in Indonesia and recent earnings beats have caught Wall Street’s attention. At the same time, its reliance on external borrowing and relatively low forecast returns on equity mean the risk reward trade off is far from straightforward for anyone looking at Grab more closely.

Grab Holdings’ superapp story, rising earnings and sharply improving margins are only half the picture. The real test is whether analyst expectations hold up against the detailed analyst forecasts for Grab Holdings

NasdaqGS:GRAB Earnings & Revenue Growth as at Jul 2026
NasdaqGS:GRAB Earnings & Revenue Growth as at Jul 2026

Clover Health Investments (CLOV)

Overview: Clover Health Investments focuses on Medicare Advantage plans for eligible individuals in the United States and supports physicians with Clover Assistant, a software platform designed to help identify and manage chronic diseases more effectively. The company combines health insurance with data tools that aim to improve care quality and medical cost control.

Operations: Clover Health Investments currently generates all of its US$2.2b in revenue from Insurance in the United States.

Market Cap: US$2.3b

Clover Health Investments may warrant closer review if you want exposure to Medicare Advantage paired with a technology driven approach to controlling medical costs. Analysts have incorporated earnings and revenue improvement into their expectations, and recent quarterly results showed revenue in the hundreds of millions and a move from a loss to a profit, indicating that its cost discipline and care model are having an impact. At the same time, the stock trades at a P/S ratio below some peers and valuation estimates, while some analysts have noted that the current share price may already reflect a demanding future P/E. Regulatory and reimbursement risks, combined with insider share sales, contribute to a complex situation in which expectations, execution and policy all play important roles.

Clover Health’s move from loss to profit, paired with a P/S ratio below some peers, hints that expectations and pricing may be starting to decouple. Get the fuller picture in the 3 key rewards and 1 important warning sign

NasdaqGS:CLOV P/S Ratio as at Jul 2026
NasdaqGS:CLOV P/S Ratio as at Jul 2026

Hyliion Holdings (HYLN)

Overview: Hyliion Holdings develops the KARNO Power Module, a fuel flexible generator that can produce on site electricity from sources ranging from natural gas and diesel to landfill gas, hydrogen and ammonia, targeting customers that need reliable, lower emissions power for data centers, industrial sites and defense applications.

Operations: Hyliion currently generates US$5.8m in revenue from Auto Parts & Accessories in the United States.

Market Cap: US$736.5m

Hyliion Holdings appears in this penny stock screener because KARNO targets some high value problems, such as reliable on site power for AI data centers and defense projects backed by ONR and DARPA, while also qualifying for policy support like a 30% investment tax credit. At the same time, the company is still pre commercial, reporting losses and relying on external funding with less than a year of cash runway. Any delay in 2026 system sales or supply chain issues around additive manufacturing and magnets could quickly pressure liquidity. Recent short seller criticism of a US$133m AI data center deal, set against new defense oriented partnerships and analyst price targets above the current share price, leaves investors weighing an ambitious opportunity against execution, credibility and funding risk.

Hyliion’s AI data center and defense power story feels only half told, with KARNO’s potential and funding risk pulling in opposite directions, and the missing context sits inside the analysis report for Hyliion Holdings

NYSEAM:HYLN Earnings & Revenue Growth as at Jul 2026
NYSEAM:HYLN Earnings & Revenue Growth as at Jul 2026

The three stocks covered here are only the first step, with the full Financially Fit Penny Stocks screener surfacing 3,587 more companies that match this financial strength theme and each carry their own potential story. Use the Financially Fit Penny Stocks screener to identify, filter and analyze the exact catalysts and narratives that matter most so you can focus on the highest conviction ideas for your own watchlist.

Take Control of Your Investment Journey

If Clover Health Investments or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Curious About What Else You Could Be Exploring?

Fresh stock ideas can move from quiet to breakout quickly, and once momentum is flying, entry points can change fast. Explore these under-the-radar picks and consider where they might fit your strategy.

  • Track cash-rich companies before momentum headlines emerge by running the list of solid balance sheet and fundamentals (47 results) to identify stocks where financial strength is already in place.
  • Look for early developments in artificial intelligence by scanning the 63 profitable AI stocks that aren't just burning cash so you can focus on businesses already turning AI demand into earnings rather than only emphasizing expansion.
  • Review the 34 power grid technology and infrastructure stocks to see companies involved in supplying grid-related projects that may not yet be widely followed.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.